connexin 33 Activators
Connexin 33 (Cx33), a member of the connexin protein family, exhibits diverse functions, including alpha-tubulin and beta-catenin binding activities, as well as gap junction channel activity. Predicted to be involved in cell-cell signaling, Cx33 is located in cellular components such as gap junctions, intercalated discs, and tight junctions, forming part of the connexin complex. Its human ortholog, GJA1, is implicated in various diseases, including craniometaphyseal dysplasia, congenital heart disease, erythrokeratodermia variabilis, oculodentodigital dysplasia, and palmoplantar keratoderma with congenital alopecia. Activation of Cx33 involves a spectrum of chemicals that modulate its expression and function, primarily influencing gap junction channel activity. Retinoic Acid, N-Acetyl-L-Cysteine, and Sodium Butyrate act as activators by affecting intracellular signaling, redox modulation, and epigenetic regulation, respectively. Forskolin and 8-Bromo-cAMP stimulate Cx33 through cAMP signaling, while Trichostatin A and Zebularine influence it through histone deacetylase inhibition and DNA demethylation, respectively.
Moreover, Valproic Acid and Lithium Chloride activate Cx33 by engaging epigenetic pathways and modulating GSK-3β activity. Alpha-Tocopherol, Dihydroergocristine, and Carnosine contribute to Cx33 activation through antioxidant properties and calcium signaling modulation. Collectively, these chemicals illustrate the intricate regulatory mechanisms governing Cx33 expression, emphasizing the impact of signaling cascades, redox modulation, and epigenetic regulation on gap junction channel activity. Understanding these activation mechanisms provides valuable insights into Cx33's role in cell-cell communication and its potential implications in diseases associated with connexin dysfunction.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic Acid upregulates connexin 33 by influencing intracellular signaling, potentially enhancing gap junction channel activity. This highlights the role of Retinoic Acid in modulating connexin 33 expression, emphasizing its impact on cell-cell communication. | ||||||
N-Acetyl-L-cysteine | 616-91-1 | sc-202232 sc-202232A sc-202232C sc-202232B | 5 g 25 g 1 kg 100 g | $34.00 $74.00 $270.00 $114.00 | 34 | |
NAC stimulates connexin 33 through redox modulation, potentially amplifying gap junction channel activity. This underscores the role of NAC in influencing connexin 33 expression, emphasizing the impact of redox signaling on cell-cell communication. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium Butyrate activates connexin 33 by inhibiting histone deacetylases, potentially enhancing gap junction channel activity. This illustrates the role of Sodium Butyrate in epigenetic modulation of connexin 33 expression, emphasizing the impact of histone acetylation on cell-cell communication. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A activates connexin 33 by inhibiting histone deacetylases, potentially enhancing gap junction channel activity. This illustrates the role of Trichostatin A in epigenetic modulation of connexin 33 expression, emphasizing the impact of histone acetylation on cell-cell communication. | ||||||
Zebularine | 3690-10-6 | sc-203315 sc-203315A sc-203315B | 10 mg 25 mg 100 mg | $129.00 $284.00 $1004.00 | 3 | |
Zebularine influences connexin 33 through DNA demethylation, potentially amplifying gap junction channel activity. This underscores the role of Zebularine in epigenetic regulation of connexin 33 expression, emphasizing the impact of DNA demethylation on cell-cell communication. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
Valproic Acid activates connexin 33 by engaging epigenetic pathways, potentially enhancing gap junction channel activity. This underscores the role of Valproic Acid in modulating connexin 33 expression, emphasizing the impact of epigenetic regulation on cell-cell communication. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
8-Bromo-cAMP stimulates connexin 33 through cAMP signaling, potentially promoting gap junction channel activity. This highlights the role of 8-Bromo-cAMP in modulating connexin 33 expression, emphasizing the impact of cAMP-mediated pathways on cell-cell communication. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium Chloride activates connexin 33 by modulating GSK-3β activity, potentially enhancing gap junction channel activity. This illustrates the role of Lithium Chloride in influencing connexin 33 expression, emphasizing the impact of GSK-3β-mediated pathways on cell-cell communication. | ||||||
DL-α-Tocopherol | 10191-41-0 | sc-294383 sc-294383A sc-294383B sc-294383C | 5 g 25 g 100 g 500 g | $26.00 $52.00 $124.00 $326.00 | 3 | |
DL-α-Tocopherol influences connexin 33 through antioxidant activity, potentially promoting gap junction channel activity. This underscores the role of Alpha-Tocopherol in modulating connexin 33 expression, emphasizing the impact of antioxidant pathways on cell-cell communication. | ||||||
Dihydroergocristine mesylate | 24730-10-7 | sc-201117 sc-201117A | 200 mg 1 g | $58.00 $255.00 | 3 | |
Dihydroergocristine mesylate activates connexin 33 through modulation of calcium signaling, potentially enhancing gap junction channel activity. This highlights the role of Dihydroergocristine in influencing connexin 33 expression, emphasizing the impact of calcium-mediated pathways on cell-cell communication. | ||||||